Phathom Pharma Exceeds Expectations Phathom Pharma recently delivered a solid earnings surprise, beating EPS estimates by $0.34 and topping revenue forecasts. The stock closed regular
Author: Dylan Evans
ABL Bio and GSK Partner to Develop Treatments for Neurodegenerative Diseases Using Grabody-B Platform
ABL Bio Inc. (KOSDAQ: 298380), a biotechnology company specializing in bispecific antibodies for immuno-oncology and neurodegenerative diseases, has announced a global licensing agreement with pharmaceutical
Palmas Strengthens Public Healthcare with Investments in Infrastructure, Medications, and Staffing
In the first 100 days of the new administration, the Palmas City Hall has made healthcare one of its top priorities. Under the leadership of
Universe Pharmaceuticals Stock Plunges to 52-Week Low Amid Mounting Challenges
Universe Pharmaceuticals Inc. is facing increasing financial pressure as its stock has dropped to a new 52-week low of just $3.20. The sharp decline reflects